Alexander Mader

Vorträge

• (2016) AllergoOncology: generation of a canine anti-EGFR anticancer IgE

  Autoren: Fazekas, J; Singer, J; Matz, M; Mader, A; Spillner, E; Kunert, R; Jensen-Jarolim, E

  Meeting of the European Academy of Allergy and Clinical Immunology 2016

• (2015) Identification of bottlenecks in antibody expression using targeted gene integration

  Autoren: Mayrhofer, P; Mader, A; Kratzer, B; Reinhart, D; Steinfellner, W; Sommeregger, W; Kunert, R

  24th ESACT 2015 - Cells, Culture, Patients, Products

• (2015) Application of Bio-Layer Interferometry for the analysis of protein/liposome interactions

  Autoren: Wallner, J; Lhota, G; Jeschek, D; Mader, A; Vorauer-Uhl, K.

  BIOMATSEN, International Congress on Biomaterials & Biosensors

• (2015) Application of Bio-Layer Interferometry for the analysis of protein/liposome interactions

  Autoren: Wallner, J; Lhota, G; Jeschek, D; Mader, A; Vorauer-Uhl, K.

  9. Deutsches BioSensor Symposium

• (2014) RMCE reference sites – A valuable tool for comparing antibody expression capabilities in CHO cells

  Autoren: Mayrhofer, P; Mader, A; Kunert, R

  16th European Congress on Biotechnology 2014

• (2014) Can225IgG, the first 'caninised' antibody against EGFR is highly effective in mediating tumor cell growth inhibition and phagocytosis in vitro

  Autoren: Fazekas, J; Singer, J; Wang, W; Weichselbaumer, M; Matz, M; Mader, A; Steinfellner, W; Meitz, S; Mechtcheriakova, D; Sobanov, Y; Willmann, M; Stockner, T; Spillner, E; Kunert, R; Jensen-Jarolim, E

  European-Academy-of-Allergy-and-Clinical-Immunology Congress 2014

• (2014) Versatile RMCE Integration of Different Antibody Variants into Predictable Reference Sites in CHO Cells

  Autoren: Mayrhofer, P; Mader, A; Kunert, R

  PEGS - Protein and Antibody Engineering Summit 2014

• (2013) Passive anti-EGFR immunotherapy in canine cancer patients - a comparative medicine study

  Autoren: Fazekas, J; Singer, J; Wang, W; Weichselbaumer, M; Matz, M; Mader, A; Steinfellner, W; Meitz, S; Mechtcheriakova, D; Sobanov, Y; Stockner, T; Spillner, E; Kunert, R; Jensen-Jarolim, E

  World Allergy and Asthma Congress of the European-Academy-of-Allergy-and-Clinical-Immunology and World-Allergy-Organization

• (2013) IgG to IgM class switch: Modification of protein properties by antibody engineering

  Autoren: Mader, A; Chromikova, V; Kunert, R

  2nd Workshop: The new ParadIgM - IgM from bench to clinic

• (2012) Human recombinant IgMs: a challenging molecule in mammalian cell expression

  Autoren: Mader, A; Kunert, R

  15th European Congress on Biotechnology ECB15 2012 - Biocrossroads

• (2011) Screening and quantification of human IgMs using BioLayer interferometry

  Autoren: Alexander Mader Renate Kunert

  The new ParadIgM 2011 - IgM from bench to clinic

• (2011) Recombinant human IgMs: Purification, characterization and modification

  Autoren: Renate Kunert

  The new ParadIgM 2011 - IgM from bench to clinic

• (2011) Anti-idiotypic antibody Ab2/3H6 mimicking gp41: a potential HIV-1 vaccine?

  Autoren: Renate Kunert Alexander Mader

  22nd meeting of the European Society for Animal Cell Technology ESACT 2011

• (2010) Humanization variants of an anti-idiotypic antibody

  Autoren: Renate Kunert, Alexander Mader, Hermann Katinger

  Human Antibodies and Hybridomas 2010

• (2009) Approaches for humanization of an anti-idiotypic murine monoclonal antibody

  Autoren: Alexander Mader, Hermann Katinger, Renate Kunert

  21st Meeting of the European Society for Animal Cell Technology ESACT 2009